BIA
NVAX icon

Barry Investment Advisors’s Novavax NVAX Stock Holding History

Barry Investment Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-600
Closed -$7K – 72
2019
Q1 		$7K Hold
600
– – ﹤0.01% 73
2018
Q4 		$22K Hold
600
– – 0.01% 72
2018
Q3 		$23K Hold
600
– – 0.01% 73
2018
Q2 		$16K Hold
600
– – 0.01% 70
2018
Q1 		$25K Hold
600
– – 0.01% 68
2017
Q4 		$15K Hold
600
– – 0.01% 71
2017
Q3 		$14K Hold
600
– – 0.01% 70
2017
Q2 		$14K Hold
600
– – 0.01% 67
2017
Q1 		$15K Hold
600
– – 0.01% 72
2016
Q4 		$15K Buy
+600
New +$17.5K 0.01% 71

Other funds holding NVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Barry Investment Advisors's NVAX Position: Q2 2019 in Review

Barry Investment Advisors sold out of Novavax (NVAX) in Q2 2019, closing a stake of 600 shares — an estimated $7K sold.

Barry Investment Advisors first reported a position in NVAX in Q4 2016 and held it in 10 quarters. The position peaked at $25K in Q1 2018. 81 funds tracked by Wall St. Rank hold NVAX as of Q2 2019.

  • Barry Investment Advisors reported no remaining Novavax position as of Q2 2019 after selling out during the quarter.
  • Barry Investment Advisors sold 600 Novavax shares in Q2 2019, an estimated $7K.
  • Barry Investment Advisors first reported a position in Novavax in Q4 2016 and held it in 10 quarters.
  • Barry Investment Advisors's Novavax position peaked at $25K in Q1 2018.
  • 81 funds tracked by Wall St. Rank held Novavax as of Q2 2019.

Based on Barry Investment Advisors's 13F filing for Q2 2019, filed 26 Jul 2019.